Human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and chlorinated analogs commonly results in pathological changes in the skin and its appendages characterized by thickening of the epidermis (acanthosis), hyperkeratosis and squamous metaplasia of the epithelial lining of the sebaceous glands. Acneform lesions (chloracne) develop as hair follicles dilate and fill with keratin and sebaceous glands become cystic. In animal models it has been found that the chloracneogenic potential of the halogenated aromatic compounds examined corresponds with the relative affinity of these same compounds for the cytosolic TCDD receptor. This receptor controls the coordinate expression of a number of inducible enzyme activities and in certain cell targets can alter normal programs of proliferation and differentiation. In this report we describe some of our ongoing studies on the mechanisms of action of TCDD in normal human epidermal cells and squamous cell carcinoma (SCC) lines. These systems permit detailed investigation of the molecular and biochemical events underlying pathologic changes in the skin and offer the potential of establishing a risk assessment model for halogenated aromatic compounds by using human target cells.
Introduction
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the prototype for the halogenated aromatic compounds including the polychlorinated biphenyls (PCBs) (1, 2) . 4 Studies in animals indicate that TCDD and isosteric analogs act through a common receptor to produce characteristic patterns oftoxic and biochemical responses (2, 3) . Toxic responses commonly observed in most animal species include a slow wasting syndrome, terator,enesis, and thymic atrophy (4) (5) (6) . Species-specific responses include hepatoxicity, edema of the pericardium, hyperkeratosis and chloracne, and at high doses, acute lethality (1, 2, (7) (8) (9) .
A number of clinical abnormalities have been reported in individuals exposed to various halogenated aromatic compounds. Chloracne is one of the most sensitive and widespread responses observed in humans (10, 11) . Other symptoms include weight loss, impaired tThe term "halogenated aromatic compounds" is commonly used to denote a large series of compounds isosteric with TCDD. These include halogenated dibenzo-p-dioxins, dibenzofurans, biphenyls, biphenylenes, and azo-and azoxybenzenes.
liver function, hepatic porphyria, general malaise, and peripheral neuropathies (12) . These are discussed in greater detail elsewhere in this volume (see section on clinical aspects of human toxicity). This report focuses on model cell culture systems for mechanistic studies on the toxicity of chlorinated aromatic compounds to the human epidermis and the potential value of these systems in risk assessment.
TCDD is the most potent of the halogenated aromatic compounds, a property presumably associated with its relative inertness to biological and chemical degradation (13) and its high affinity for the cytosolic receptor (14) . Other members of this class which are more readily metabolized, such as the PCBs, possess similar affinities for the cytosolic receptor measured in vitro (15) , but vary widely in their toxic potency (1, 3) , indicating the importance of considering both pharmacokinetic and mechanistic studies in estimating human health risks.
Ah Locus: Role in Mediating Toxicity of Chlorinated Aromatic Compounds
In certain inbred murine strains, the induction by TCDD of cytochrome(s) P1-450 and several associated monooxygenase activities, including aryl hydrocarbon hydroxylase (AHH) and 7-ethoxycoumarin 0-deethylase (ECOD), is regulated by a single genetic locus (designated the Ah locus) and its putative gene product, the TCDD receptor protein (14, 16, 17) . In these same murine strains, TCDD-induced thymic atrophy and cleft palate formation segregate with the Ah locus (18) . Recent investigations have also shown that TCDD produces epidermal hyperplasia (19) and promotes skin papillomas (20) in hairless mice bearing the recessive mutation hrlhr. Further, the data indicate that TCDDinduced epidermal hyperplasia requires interaction between two regulatory gene loci, Ah and hr (19) . Based on these and other findings (2, (18) (19) (20) , it has been postulated that the murine Ah locus, either singly or in concert with other regulatory genes, controls at least two distinct pleiotropic responses: a limited, but widely expressed gene battery which includes the structural genes for cytochrome(s) P1-450, and in a few organs such (22) . Chromosome mapping in mouse-human cell hybrids suggests that either the structural or the regulatory genes for the induction of AHH activity are located on human chromosome 2; however, participation of mouse genes in the observed response is not ruled out (24) .
We examined the responsiveness of cultured human squamous cell carcinoma (SCC) lines derived from tumors of the epidermis and tongue to TCDD by measuring the induction of ECOD activity ( Fig. 1) (25) . In four of the SCC lines, the EC50 (concentration required to elicit 50% of the maximal response) is approximately 1i0 M, whereas in one line the EC50 is 10-10 M. In each of the less sensitive lines a concentration of 10-10 M TCDD elicits less than 5% of the maximal enzyme activity. Specific binding of radiolabeled TCDD is detected in the cytosol fraction from all the SCC lines (Table 1 ) and the relative amount of receptor in each line correlates with maximally induced ECOD activity (25) . These data indicate that human cell lines derived from a target tissue for TCDD toxicity contain the TCDD receptor and show differential sensitivity to TCDD 1 -7 (25) . analogous to the murine strain differences in sensitivity regulated by the Ah locus (25) .
Model Cell Culture Systems to Study Mechanisms of Epidermal Toxicity
The skin lesions produced by TCDD and halogenated isostereomers are typified by thickening of the epidermis (acanthosis), hyperkeratosis and squamous metaplasia of the epithelial lining of the sebaceous glands (4, 8) . Acneform lesions develop as hair follicles dilate and become filled with keratinaceous material and sebaceous glands become cystic (12) . In animal models the available data on structure-activity relationships indicate that the chloracneogenic potential of halogenated aromatic compounds corresponds with the capacity of these same compounds to bind to the TCDD receptor and evoke biochemical and toxic responses in other tissues (2, 18, 19, 26, 27) . It would appear that the same structure-activity relationship can be used to predict skin toxicity in humans (2, 28) .
Two epithelial keratinizing cell types have been successfully serially cultivated by using lethally irradiated 3T3 murine fibroblast feeder layers; XB cells, a cell line derived from a mouse teratoma (29) ; and normal human epidermal cells, usually obtained from neonatal foreskin (30) . Monoclonal colonies consisting of multiple cell layers appear in culture. Within each colony, proliferating cells are confined to the basal layer. As cells migrate to upper layers, they lose their capacity to divide and begin the process of terminal differentiation. This is marked by an increase in cell size, changes in keratin expression, and the formation of crosslinked cornified envelopes (31) . Flattened and elongated squames are shed into the media.
TCDD elicits a concentration-dependent keratinization response in cultured murine XB cells (32) . It was suggested that the keratinization response in these cells was mediated by the TCDD receptor based on doseresponse parameters and structure-activity relationship data comparing the potencies of halogenated aromatic compounds to induce keratinization in XB cells with their relative affinities for the TCDD receptor in murine hepatic cytosol (32) .
We have found that TCDD enhances stratification (Fig. 2 ) and induces hyperkeratinization (as judged by the intensity of Rhodanile Blue staining, Fig. 3 ) in early passage human epidermal cells (33) . These responses to TCDD are associated with a 30 to 40% inhibition of both basal and epidermal growth factor (EGF)-stimulated DNA synthesis (33) . Similar results were observed in a human SCC line (SCC-12F) with growth requirements similar to normal epidermal cells (33, 34) . These findings are consistent with an enhanced commitment of proliferating basal cells to terminal differentiation and suggest that these in vitro systems are appropriate models for hyperkeratinization observed in vivo (4, 12) .
Regulation of Biochemical Mediators of Human Epidermal Cell Proliferation by TCDD
The proliferation and differentiation of epidermal cells are regulated by several biochemical mediators including hydrocortisone, cyclic nucleotides and EGF (31) . In the previous section it was noted that TCDD enhances keratinization and inhibits EGF-stimulated DNA synthesis in SCC-12F cells. As shown in Figure 4 , treatment of these cells with TCDD results in a concentrationdependent decrease in the specific binding of EGF to a value 40% of control with an EC of 1 nM. Scatchard analysis of EGF binding indicates that TCDD exposure results in a loss of high affinity (Kd = 2.8 x 10-10 M) EGF binding sites (34, 35) .
A structure-activity relationship for down regulation of EGF binding is shown in Table 2 . The response of cells treated with 2,3,7,8-tetrachloro-dibenzofuran, an isostereomer of TCDD, is equal to that with TCDD, whereas no significant alteration in EGF binding occurs in cells treated with the nonisostereomeric analog, 2,7-dichlorodibenzo-p-dioxin. The observed stereospecificity (Table 2) and potency (EC50 = 1 nM, Fig. 4 ) suggest that the down regulation of EGF receptors in SCC-12F cells by TCDD is mediated by the TCDD receptor.
The kinetics of inhibition of EGF binding in SCC-12F cells by TCDD and benzo(a)pyrene differ (Table 3) . Maximum inhibition induced by benzo(a)pyrene, an agent which inhibits EGF binding in C3H1OT1/2 cells (36) and hepatoma cell lines (37), occurs within 24 hr. with 90% recovery by 48 hr. In contrast, TCDD requires 72 hr to produce maximum inhibition, and no recovery is observed 10 days after removal of TCDD from the culture medium (34, 35) . TCDD produces hyperkeratinization in SCC-12F cells (33) and is characterized by its ability to produce a prolonged decrease in EGF binding. ; same field as in C but focused on a more superficial cell layer. Note the loosely adherent squames, which lack discernible intracellular organelles, as indicated by the arrowheads. Cells were plated at a density of 5 x 103 cells/60 mm plastic culture dish and were grown as described in the legend to Fig. 1 (38) . In initial studies we have examined the actions of TCDD on the regulation of adenylate cyclase activity in human SCC lines with different growth responses to TCDD. Under appropriate culture conditions, treatment of line SCC-9 with TCDD enhances colony expansion (39) , whereas in line SCC-12F, TCDD inhibits colony expansion (39) . In SCC-9 cells TCDD appears -to act through a unique membrane receptor mechanism to stimulate adenylate cyclase activity nearly 2-fold (40) . The mechanisms for the modulation of adenylate cyclase activity by TCDD are not known; however, preliminary evidence suggests that TCDD may alter the responsiveness of the cyclase system to several wellcharacterized homone activators (M. J. Young, personal communication).
Summary and Conclusions
Treatment of early passage normal epidermal cells in culture with TCDD enhances stratification in cell colonies (Fig. 2) , increases keratinization in confluent cul- (Fig. 3) and inhibits both basal and EGFstimulated DNA synthesis (33, 34) . These results indicate enhanced cell differentiation in the presence of TCDD and suggest that TCDD stimulates the commitment of proliferating basal cells to a program of terminal differentiation.
Using prototype SCC lines which under certain culture conditions display enhanced proliferation (SCC-9) and differentiation (SCC-12F) in the presence of TCDD, studies were carried out to determine potential biochemical mechanisms for these responses. In SCC-12F cells, TCDD treatment results in a selective loss of high affinity EGF receptors (34, 35) rendering these cells refractory to the growth stimulating effects of EGF. The dose-response parameters (Fig. 4) and stereospecificity (Table 2 ) of this response suggest that altered regula- (Fig. 1) and differential growth responses to TCDD (25, 33) , suggest that these cells have a further relevance in reflecting genetically determined differences in susceptibility to TCDD toxicity.
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